NIMML Director to Discuss How to Build a Company Through Breakthrough Research at the NEXUS SUMMIT

Virginia Tech is helping build an entrepreneurial community through the Nexus Summit. The event is designed to showcase how Virginia Tech is investing in students, faculty and alumni to help them be more successful as entrepreneurs and innovators. Dr. Bassaganya-Riera will discuss how Virginia Tech’s Nutritional immunology and Molecular Medicine Laboratory through breakthrough research helped establish BioTherapeutics, a science-based biotech Company that develops disruptive small-molecule drugs to treat inflammation and diabetes.

About NIMML

The NIMML Institute is a 501 (c) (3) non-profit public charity foundation focused on a transdisciplinary, team-science approach to precision medicine at the interface of immunology, inflammation, and metabolism. The NIMML Institute team has led numerous large-scale transdisciplinary projects and is dedicated to solving important societal problems by combining the expertise of immunologists, computational biologists, toxicologists, modelers, translational researchers, and molecular biologists. The Institute is headquartered in Blacksburg, VA. For more information, please visit www.nimml.org or contact pio@nimml.org.